Filing Flows › Comparisons › SNY vs LLY
Sanofi vs ELI Lilly: SNY and LLY compared
Sanofi is the larger company: $43.6B of revenue in its latest quarter (FY2025) against $24.4B for ELI Lilly (Q3 2026). ELI Lilly is growing faster (+39% against +6% a year earlier). ELI Lilly is more profitable, with an operating margin of 34.5% against 14.5%.
Where the money goes: SNY and LLY
Sanofi (SNY) · FY2025
Sanofi, FY2025: revenue $43.6B (+6% year over year), operating margin 14.5%, net earnings $7.8B, operating cash flow $10.8B. The chart follows the revenue to costs, profit and cash.
ELI Lilly (LLY) · Q3 2026
ELI Lilly, Q3 2026: revenue $24.4B (+39% year over year), operating margin 34.5%, net earnings $6.5B, operating cash flow $11.4B. The chart follows the revenue to costs, profit and cash.
| Sanofi (SNY) | ELI Lilly (LLY) | |
|---|---|---|
| Latest quarter | FY2025 | Q3 2026 |
| Revenue | $43.6B | $24.4B |
| Revenue growth, Y/Y | +6% | +39% |
| Gross margin | 77.2% | — |
| Operating margin | 14.5% | 34.5% |
| Net earnings | $7.8B | $6.5B |
| Net margin | 17.9% | 26.4% |
| Operating cash flow | $10.8B | $11.4B |
| Free cash flow | — | $8.2B |
| Market value | $57.4B | $1.22T |
| P/E | — | 44.3× |
| Analysts’ mean target | $53.48 | $1453.40 |
Where the revenue comes from
ELI Lilly
- Net product revenue: $22.7B (93%)
- Other oncology: $1.1B (4%)
- Other immunology: $579M (2%)
Questions
Which is bigger, Sanofi or ELI Lilly?
Sanofi is the larger company: $43.6B of revenue in its latest quarter (FY2025) against $24.4B for ELI Lilly (Q3 2026).
Is Sanofi or ELI Lilly growing faster?
ELI Lilly is growing faster (+39% against +6% a year earlier).
Which is more profitable, Sanofi or ELI Lilly?
ELI Lilly is more profitable, with an operating margin of 34.5% against 14.5%.
More: Sanofi earnings · how Sanofi makes money · ELI Lilly earnings · how ELI Lilly makes money
From the companies' latest 10-Q, 10-K or earnings release (20-F filed Feb 17, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.